Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summerâs Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreauxâs Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPBH
āļāļ·āđāļāļāļĢāļīāļĐāļąāļPrestige Consumer Healthcare Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 10, 2005
āļāļĩāļāļĩāđāļLombardi (Ronald M)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ600
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 10
āļāļĩāđāļāļĒāļđāđ660 White Plains Rd.
āđāļĄāļ·āļāļTARRYTOWN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ10591
āđāļāļĢāļĻāļąāļāļāđ19145246800
āđāļ§āđāļāđāļāļāđhttps://www.prestigebrands.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPBH
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 10, 2005
āļāļĩāļāļĩāđāļLombardi (Ronald M)
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
Ms. Sheila A. Hopkins
Independent Director
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
Ms. Dawn M. Zier
Independent Director
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Mr. James C. D'arecca
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
Ms. Sheila A. Hopkins
Independent Director
Invesco Pharmaceuticals ETF
State Street SPDR S&P Pharmaceuticals ETF
Schwab Ariel Opportunities ETF
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Invesco S&P SmallCap Health Care ETF
iShares U.S. Pharmaceuticals ETF
Brandes US Small-Mid Cap Value ETF
Invesco S&P SmallCap Low Volatility ETF
JPMorgan Active Small Cap Value ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Invesco Pharmaceuticals ETF
āļŠāļąāļāļŠāđāļ§āļ2.44%
State Street SPDR S&P Pharmaceuticals ETF
āļŠāļąāļāļŠāđāļ§āļ2.43%
Schwab Ariel Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
āļŠāļąāļāļŠāđāļ§āļ2.05%
Congress SMid Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.94%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.83%
iShares U.S. Pharmaceuticals ETF
āļŠāļąāļāļŠāđāļ§āļ1.1%
Brandes US Small-Mid Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.84%
Invesco S&P SmallCap Low Volatility ETF
āļŠāļąāļāļŠāđāļ§āļ0.71%
JPMorgan Active Small Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.68%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ